1. Apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of Japanese patients with moderate to severe plaque psoriasis: Efficacy, safety and tolerability results from a phase 2b randomized controlled trial. Issue 8 (9th April 2017) Authors: Ohtsuki, Mamitaro; Okubo, Yukari; Komine, Mayumi; Imafuku, Shinichi; Day, Robert M.; Chen, Peng; Petric, Rosemary; Maroli, Allan; Nemoto, Osamu Journal: Journal of dermatology Issue: Volume 44:Issue 8(2017) Page Start: 873 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Experimental Hbsag/Anti-Hbs Complex Assay for Prediction of Hbeag Loss in Chronic Hepatitis B Patients Treated with Pegylated Interferon and Adefovir. Issue 3 (April 2014) Authors: de Niet, Annikki; Jansen, Louis; Zaaijer, Hans L; Klause, Ursula; Takkenberg, Bart; Janssen, Harry LA; Chu, Tom; Petric, Rosemary; Reesink, Hendrik W Journal: Antiviral therapy Issue: Volume 19:Issue 3(2014) Page Start: 259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pharmacodynamic analysis of apremilast in Japanese patients with moderate to severe psoriasis: Results from a phase 2b randomized trial. Issue 1 (10th September 2020) Authors: Imafuku, Shinichi; Nemoto, Osamu; Okubo, Yukari; Komine, Mayumi; Schafer, Peter; Petric, Rosemary; Ohtsuki, Mamitaro Journal: Journal of dermatology Issue: Volume 48:Issue 1(2021) Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Population pharmacokinetic and exposure–response analysis of apremilast in Japanese subjects with moderate to severe psoriasis. Issue 11 (15th August 2021) Authors: Okubo, Yukari; Ohtsuki, Mamitaro; Komine, Mayumi; Imafuku, Shinichi; Kassir, Nastya; Petric, Rosemary; Nemoto, Osamu Journal: Journal of dermatology Issue: Volume 48:Issue 11(2021) Page Start: 1652 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗